Price Chart
Key Statistics
Market Cap(EOD)55.05M
Enterprise Value55.05M
P/E Ratio (TTM)N/A
P/B Ratio (TTM)N/A
P/S Ratio (TTM)N/A
Earnings Yield (TTM)N/A
ROE (TTM)0.00%
ROIC (TTM)0.00%
Net Profit Margin (TTM)N/A
Dividend Yield (TTM)N/A
Payout Ratio (TTM)N/A
Debt/Equity (TTM)0.00
About ProShares Ultra Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.